HMPL-689
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for HMPL-689, covering 2017-08-17 to 2025-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas [Phase 1]